摘要
揭示了许多神经退行性疾病和脑肿瘤的分子途径,为引进选择性外源基因疗法铺平了道路。所涉及的活性生物分子主要包括负电荷的核酸,从DNA、mRNA、非编码RNAs(小干扰RNA、siRNA和microRNA、miRNA)到反义寡核苷酸。它们选择性地干扰基因的翻译和/或转录过程。 尽管许多评论以前处理的脑靶向性,这些生物大分子之间的分子特性深入相关,血脑屏障(BBB)的性质在相应的病理条件下,细胞内的目标,以及输送系统将运输货物到靶细胞的生物活性进行有效的传递到大脑的活跃网站设计将被评。 在本文中,我们将进一步讨论在非病毒基因传递系统目前研究的巨大进步(从自组装nanoplexes使用阳离子聚合物或脂质和通过脂质体,适体,多聚体,外体,树枝状聚合物和纳米粒子)。不像以前关于这个主题的评论,该载体表面受体结合促进脑细胞或细胞内靶向将突出功能化策略,根据CNS疾病的条件与智能体剪裁特别强调。此外,新开发的评价方法,细胞培养模型研究脑屏障通透性和操纵脑屏障功能的聚焦超声将得到解决…
关键词: 纳米载体,脑内传递,神经退行性疾病、脑胶质瘤、脑蛋白、基因传递、mRNA
Current Gene Therapy
Title:Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier
Volume: 17 Issue: 2
关键词: 纳米载体,脑内传递,神经退行性疾病、脑胶质瘤、脑蛋白、基因传递、mRNA
摘要: The restless endeavors revealing the molecular pathways underlying many neurodegenerative diseases and brain tumors have paved the way for the introduction of the selective exogenous gene-based therapeutics. The implicated active biomolecules encompass mainly negatively-charged nucleic acids ranging from DNA, mRNA, non-coding RNAs (small-interfering RNA, siRNA, and microRNA, miRNA), to antisense oligonucleotides. They selectively interfere with the genes translational and/or transcriptional processes.
Although many reviews previously addressed brain targeting, a thorough correlation between the molecular properties of these biomacromolecules, the nature of blood brain barrier (BBB) in the accompanying pathological condition, the intracellular targets, as well as the design of the delivery system which will transport the bioactive cargo to the target cells attempting efficient delivery to the active sites in the brain will be appraised. In this review, we will further discuss the tremendous advances in non-viral gene delivery nanosystems currently investigated (starting from self-assembled nanoplexes using cationic polymers or lipids and going through liposomes, aptamers, polymersomes, exosomes, dendrimers and nanoparticles). Unlike previous reviews on this topic, functionalization strategies of the nanocarriers promoting either surface receptor binding or intracellular targeting of the cranial cells will be highlighted, with special emphasis on tailoring smart nanomedicines according to the CNS disease condition. In addition, newly-developed evaluation approaches, cell culture models studying BBB permeability and manipulation of the barrier function of the brain via focused ultrasound will be addressed.Export Options
About this article
Cite this article as:
Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier, Current Gene Therapy 2017; 17 (2) . https://dx.doi.org/10.2174/1566523217666170510155803
DOI https://dx.doi.org/10.2174/1566523217666170510155803 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Suppression of HIV Replication In Vitro by CpG and CpG Conjugated to the Non Toxic B Subunit of Cholera Toxin
Current HIV Research Nanotechnology in Neuroscience and its Perspective as Gene Carrier
Current Topics in Medicinal Chemistry α-Melanocyte Stimulating Hormone as a Potential Therapy for Alzheimer's Disease
Current Alzheimer Research Autotaxin and Lysophosphatidic Acid Receptors as Novel Targets for the Radiosensitization of Tumor Vasculature in Non-Small Cell Lung Cancer
Current Angiogenesis (Discontinued) Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity
Current Medicinal Chemistry Pharmacological Perspectives of Wasp Venom
Protein & Peptide Letters The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy
Central Nervous System Agents in Medicinal Chemistry Advanced Platelet-Rich Fibrin Extract Treatment Promotes the Proliferation and Differentiation of Human Adipose-Derived Mesenchymal Stem Cells through Activation of Tryptophan Metabolism
Current Stem Cell Research & Therapy Exosomes: A Promising Factor Involved in Cancer Hypoxic Microenvironments
Current Medicinal Chemistry Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis
Current Medicinal Chemistry Current Perspective of Natural Alkaloid Carbazole and its Derivatives as Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry Update on Cancer Related Issues of Mesenchymal Stem Cell-Based Therapies
Current Stem Cell Research & Therapy Regulatory T Cells in Central Nervous System: in Health and Disease
Central Nervous System Agents in Medicinal Chemistry Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Current Medicinal Chemistry Myogenic Potential of Mesenchymal Stem Cells - the Case of Adhesive Fraction of Human Umbilical Cord Blood Cells
Current Stem Cell Research & Therapy Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
Current Neuropharmacology The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders I: Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Tumour Gene Therapy Monitoring Using Magnetic Resonance Imaging and Spectroscopy
Current Gene Therapy Epigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design A Review of the Biological Activities of Heterocyclic Compounds Comprising Oxadiazole Moieties
Current Topics in Medicinal Chemistry